TRH Financial’s Pfizer PFE Stock Holding History

TRH Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,932	Closed	-$204K	–	76
2022 Q1	$204K	Buy	3,932 +22	+0.6%	+$1.14K	0.06%	75
2021 Q4	$231K	Buy	+3,910	New	+$194K	0.07%	72
2021 Q3	–	Sell	-5,440	Closed	-$213K	–	70
2021 Q2	$213K	Sell	5,440 -675	-11%	-$26.2K	0.09%	68
2021 Q1	$222K	Buy	6,115 +229	+4%	+$8.13K	0.11%	71
2020 Q4	$217K	Sell	5,886 -435	-7%	-$16K	0.12%	68
2020 Q3	$220K	Buy	+6,321	New	+$222K	0.15%	63
2019 Q4	$423K	Buy	+11,495	New	+$409K	0.37%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TRH Financial's PFE Position: Q2 2022 in Review

TRH Financial sold out of Pfizer (PFE) in Q2 2022, closing a stake of 3,932 shares — an estimated $204K sold.

TRH Financial first reported a position in PFE in Q4 2019 and held it in 7 quarters. The position peaked at $423K in Q4 2019. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

TRH Financial reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
TRH Financial sold 3,932 Pfizer shares in Q2 2022, an estimated $204K.
TRH Financial first reported a position in Pfizer in Q4 2019 and held it in 7 quarters.
TRH Financial's Pfizer position peaked at $423K in Q4 2019.
3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on TRH Financial's 13F filing for Q2 2022, filed 26 Jul 2022.